Two Novel Mutations in the Spastin Gene of Chinese Patients with Hereditary Spastic Paraplegia

Q. -Z. Fei,W. -G. Tang,T. -Y. Rong,H. -D. Tang,J. -R. Liu,Z. -L. Guo,Y. Fu,Q. Xiao,X. -J. Wang,S. -B. He,L. Cao,S. -D. Chen
DOI: https://doi.org/10.1111/j.1468-1331.2011.03358.x
2011-01-01
European Journal of Neurology
Abstract:Background and purpose: Hereditary spastic paraplegia (HSP) is a clinically and genetically heterogeneous group of neurodegenerative diseases. Mutations in the spastin (SPG4) gene are responsible for approximately 40% of autosomal dominant HSP (AD-HSP) and 6.5-18% of sporadic cases.Methods: Spastin mutations were screened in 11 AD-HSP families and 11 sporadic cases by direct sequencing and MLPA assay. Novel mutations were detected in 100 healthy controls by PCR-RFLP.Results: We identified seven different spastin mutations in five probands and one sporadic patient. Two of seven mutations were novel. The c.458delT was a pathogenic mutation, but the effect of c. 1724 G>T remained unknown.Conclusions: This study allowed us to estimate the frequency of the SPG4 mutations in Chinese at 45% (5/11) in families with AD-HSP and 9% (1/11) in sporadic cases. In addition, our data showed p.T614I was not associated with congenital arachnoid cysts.
What problem does this paper attempt to address?